Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Clinical trial NCT06762769 · RECRUITING
Trial details
- NCT number
- NCT06762769
- Sponsor
- University College, London
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-02
- Primary completion
- 2032-11-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.